| __timestamp | Supernus Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 122045000 | 1777824000000 |
| Thursday, January 1, 2015 | 144427000 | 1807378000000 |
| Friday, January 1, 2016 | 215003000 | 1732051000000 |
| Sunday, January 1, 2017 | 302238000 | 1770531000000 |
| Monday, January 1, 2018 | 408897000 | 2097224000000 |
| Tuesday, January 1, 2019 | 392755000 | 3291188000000 |
| Wednesday, January 1, 2020 | 520397000 | 3197812000000 |
| Friday, January 1, 2021 | 579775000 | 3569006000000 |
| Saturday, January 1, 2022 | 667238000 | 4027478000000 |
| Sunday, January 1, 2023 | 607521000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unleashing insights
In the competitive world of pharmaceuticals, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outperformed Supernus Pharmaceuticals, Inc. in terms of revenue. From 2014 to 2023, Takeda's revenue surged by approximately 140%, reaching a staggering $4.26 trillion in 2023. In contrast, Supernus Pharmaceuticals, Inc. experienced a more modest growth of around 400%, with revenues peaking at $667 million in 2022.
This stark difference highlights Takeda's dominant presence in the global market, driven by its expansive product portfolio and strategic acquisitions. Meanwhile, Supernus, with its focus on niche markets, has shown impressive growth relative to its size, yet remains a smaller player in the industry. As we look to the future, the absence of 2024 data for Supernus suggests potential challenges or strategic shifts on the horizon.
Johnson & Johnson and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Sanofi or Takeda Pharmaceutical Company Limited?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Corcept Therapeutics Incorporated
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or ACADIA Pharmaceuticals Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Incyte Corporation or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. vs Geron Corporation: Examining Key Revenue Metrics
Supernus Pharmaceuticals, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared